The American Society Of Clinical Oncology 2004 Annual Meeting was held June 4-7, 2004, in New Orleans, Louisiana.
The IMF is grateful to the investigators and presentors who contributed their time to provide this update and hopes that you will find it informative and useful. To get started, first select a speaker from the list below, then:
A randomised phase III trial of thalidomide {Thalomid®}plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00): A trial coordinated by the Eastern Cooperative Oncology Group
print
back to top